newdrugapprovals.org
FDA approves first drug Actemra (tocilizumab) to specifically treat giant cell arteritis
FDA approves first drug to specifically treat giant cell arteritis 05/22/2017 The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat ad…